CSI Market
Sign In | Register

Jazz Pharmaceuticals Plc (JAZZ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access JAZZ Annual Cash Flow →
Quarterly cash flow trends provide additional context on Jazz Pharmaceuticals Plc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
9 Months 		(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Operating Activities
Income2.50
Depreciation & amortization25.30
Amortization of Other Assets514.10
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories123.30
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets122.80
Share-based Compensation225.00
Proceeds from Equity Method Investment, Dividends or Distributions-0.10
Gains (Losses) on Extinguishment of Debt2.40
Increase Decrease In Deferred Rent-
Fair Value Inventory Step Up Adjustment-
Provision For Losses On Accounts Receivable And Inventory14.20
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Increase Decrease In Operating Lease Assets-
Inventory Step Up Value Adjustment37.50
Increase Decrease In Contract With Customer Liability-
Noncash Interest Expense4.70
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable44.60
Increase (Decrease) in Accounts Payable8.80
Increase (Decrease) in Accrued Liabilities-13.80
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-76.10
Other Working Capital0.10
Other Noncash Income (Expense)-1.60
Other net0.00
Payments for (Proceeds from) Other Operating Activities352.70
Discontinued operations0.00
Net Cash flow from Operating Activities1,330.00
Investing Activities
Capital Expenditures-131.20
Sale of Capital Items200.00
Short-term Investments Proceeds0.00
Payments to Acquire Available-for-sale Securities0.00
Real Estate Investments0.00
Payments To Acquire Product Rights-
Paymentsto Acquire In Process Research and Development Other Than Through Business Combination-
Payment To Acquire Assets Net Of Cash Acquired-
Payments To Acquire In Process Research And Development Other Than Through Business Combination-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments230.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Assets, Investing Activities-830.80
Payments to Acquire Additional Interest in Subsidiaries0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-73.80
Discontinued operations0.00
Net Cash Flow from Investing Activities-605.80
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-5.20
Long-term debt - borrowings1,225.90
Long-term debt - repayments-1,023.30
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-158.80
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-117.90
Other net0.00
Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants-
Proceeds From Stock Options And Warrants Exercises-
Proceeds From Issuance Of Term Loan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-79.30
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1,398.80
Total Cash Flow644.50
4 historic quarters locked

Sign in to unlock the full Jazz Pharmaceuticals Plc cash flow history.

Sign In Create Free Account

About Jazz Pharmaceuticals Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001232524-26-000057

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI